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The data presented herein expand the current understanding of
the modulatory function of opioid drugs in mouse macrophage
activity described in our relevant research article (Filipczak-Bry-
niarska et al., 2017) [1], in which we characterize the influence of
morphine, buprenorphine and oxycodone on humoral and cell-
mediated immune response in mice. Among other things, we have
shown the effects of treatment with assayed analgesics on mac-
rophage ability to induce antigen-specific B-cell response to sheep
red blood cells as well as to generate reactive oxygen inter-
mediates and nitric oxide. The current data demonstrate the
effects of morphine, buprenorphine or oxycodone administration
on phagocytosis of sheep red blood cells and zymosan by mouse
macrophages, supplementing the data on immune modulatory
capacities of assayed drugs, recently reported by us (Filipczak-
Bryniarska et al., 2017; Kozlowski et al., 2017) [1,2].
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).ier Inc. This is an open access article under the CC BY license
intimp.2017.11.039
K. Bryniarski).
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ject areaImmunopharmacologyype of data Figure
ow data was
acquiredUsing flow cytometry on FACS Calibur with BD CellQuest Pro software (BD
Bioscience, San Jose, CA, USA)ata format Analyzed
xperimental
factors– Treatment of mouse donors of macrophages with proper opioid drug
– Injection of mineral oil for induction of macrophage-enriched peritoneal
exudate
– Collection of macrophages for in vitro incubation with either FITC-coupled
sheep red blood cells or zymosan-green
– Cytometric analysis of macrophages
xperimental
features– Mouse donors of macrophages were treated for 7 consecutive days with one
of tested opioid drugs
– Macrophage-enriched peritoneal exudate was induced by mineral oil injec-
tion on 2nd day of drug treatment
– Yielded macrophages were incubated with either ex tempore FITC-coupled
sheep red blood cells or commercially available zymosan-green
– Macrophages were analyzed cytometrically for the intensity of green fluor-
escence emittedata source
locationDepartment of Immunology, Jagiellonian University Medical College, Krakow,
Polandata accessibility Data is within this articleValue of the data
 The data presented here demonstrate the effects of morphine, buprenorphine or oxycodone
administration on phagocytosis of either FITC-coupled sheep red blood cells or zymosan-green by
mouse macrophages.
 While zymosan-green reagent is commercially available, we have elaborated another, original
phagocytosis assay with the use of FITC-coupled sheep red blood cells, prepared by us ex tempore.
 The opioid analgesics were administered in vivo prior to macrophage harvest, which enables to
evaluate their influence on immune cells taking into account the pharmacodynamics, tissue dis-
tribution and metabolism of tested drugs in living organism.1. Data
The percentage of macrophages from mice treated with different opioid drugs emitting green
fluorescence after incubation with fluorescein isothiocyanate (FITC)-coupled sheep red blood cells
(Fig. 1, upper left graph) or with zymosan-green reagent (Fig. 1, upper right graph), and the geometric
mean of emitted green fluorescence by these macrophages incubated with FITC-coupled sheep red
blood cells (Fig. 1, lower left graph) or with zymosan-green reagent (Fig. 1, lower right graph). In
addition, macrophage populations were divided into cells expressing high (FITChigh, grey bars) or low
(FITClow, black bars) green fluorescence emission. The raw data are included in supplementary table.
Fig. 1. Opioid analgesics influence phagocytosis of fluorescein isothiocyanate (FITC)-coupled sheep red blood cells (SRBC) and
zymosan-green by mouse macrophages. Oil-induced, peritoneal macrophages harvested from mice treated for a week with
morphine, buprenorphine or oxycodone were incubated for 20 min in 37 °C water-bath with SRBC-FITC or zymosan-green
reagent, and then green fluorescence emission by these cells was measured cytometrically. Upper left graph shows the per-
centage of macrophages of mice treated with respective opioid drug that emit green fluorescence after incubation with SRBC-
FITC, while upper right graph shows the percentage of macrophages emitting green fluorescence after incubation with
zymosan-green reagent. Lower left graph demonstrates the geometric mean of emitted green fluorescence by control and
opioid-treated macrophages incubated with SRBC-FITC and lower right graph depicts the geometric mean of emitted green
fluorescence by control and opioid-treated macrophages incubated with zymosan-green reagent. According to the intensity of
green fluorescence signal, macrophage populations were divided into cells expressing high (FITChigh, grey bars) or low (FITClow,
black bars) fluorescence emission.
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2.1. Mice
Ten week old male mice (22 7 2 g) of the inbred CBA strain were from the breeding unit of the
Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Krakow,
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treatment groups, animals were subjected to the experiment conducted according to the guidelines of
the 1st Local Ethics Committee in Krakow (approval No 123/2013).2.2. Opioid drug administration, mineral oil injection and harvest of macrophages
Mice were treated intraperitoneally for 7 consecutive days with sterile Dulbecco's phosphate
buffered saline (DPBS) solutions of following drugs: morphine sulfate (02DR0910, WZF Polfa S.A.,
Warsaw, Poland) administered twice daily in a single dose of 20 mg/kg per mouse [1–3], buprenor-
phine (01AF0512, WZF Polfa S.A., Warsaw, Poland) given once a day in a dose of 2 mg/kg per mouse
[1,2], and oxycodone hydrochloride (AB465, Mundipharma Polska Sp. z o.o., Warsaw, Poland)
administered twice daily in a single dose of 20 mg/kg per mouse [1,2]. To induce macrophage-enri-
ched peritoneal exudate, on the 2nd day of drug administration mice were injected intraperitoneally
with 1 ml of mineral oil heavy fraction (Sigma, St. Louis, MO, USA) [1–3]. Five days later peritoneal
exudate containing over 95% of macrophages was harvested by washing the peritoneal cavity with
ice-cold DPBS containing heparin (5 U/ml) [1–3] and, after washing, macrophages were used in the
in vitro phagocytosis assay.2.3. Preparation of FITC-coupled sheep red blood cells (SRBC)
Powdered FITC (Sigma, St. Louis, MO, USA) was dissolved in Tris-HCl buffer (pH 9.0) to reach the
concentration of 50 mg/ml. Then it was diluted 10 times with DPBS, adjusted to pH 8.0, and 10 ml of
the final FITC solution was mixed with 1 ml of 100% suspension of SRBC (Graso Biotech, Starogard
Gdanski, Poland), washed previously with DPBS, and incubated for 2 h at room temperature, in
darkness, on hematological roller. Afterwards, SRBC-FITC were washed thrice with DPBS, filtered
through nylon mesh and 1% suspension in DPBS was prepared for the phagocytosis assay.2.4. Phagocytosis assay and cytometric analysis
Macrophages harvested from either drug-treated or untreated (control) mice were incubated with
SRBC-FITC (in ratio 1:10) for 20 min in 37 °C water-bath, which was followed with osmotic shock for
lysis and removal of non-phagocytosed SRBC-FITC. Otherwise, macrophages were incubated with
zymosan-green reagent (pHrodoTM Green Zymosan A BioParticles Conjugate; Life Technologies,
Carlsbad, CA, USA), previously prepared according to manufacturer procedures, in a dose of 0.25 mg
of zymosan per 5 × 106 macrophages for 20 min in 37 °C water-bath. Then cells were analyzed by flow
cytometry on FACS Calibur (BD Bioscience, San Jose, CA, USA), and acquired data were analyzed firstly
with BD CellQuest Pro software, and then with GraphPad Prism and Excel software.Acknowledgements
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